Cover Story
The pharma industry is looking to emerging markets for growth
Agarwal Packers and Movers Ltd (APML), a globally recognised logistics company, recently ventured into the pharma logistics segment. Ramesh Agarwal, Chairman, Agarwal Packers and Movers, in an interaction with Sachin Jagdale, reveals more about his compan
Sikkim: The Potential Pharma Hub
Thanks to the North-East Industrial and Investment Promotion Policy (NEIIPP) 2007, Sikkim has been able to offer a host of tax benefits to the industry. Thus it is no wonder that the state has already
Brace for BREXIT
Post-Brexit, a strategic realignment can help India emerge as a significant partner for pharmaceuticals in the both the EU and the UK By Usha Sharma and Lakshmipriya Nair
Are We Grappling Skewed Perceptions of GMP?
Indian Pharma Inc's waking up to the importance of GMP compliance and it has become a top priority in board room meetings but there is a need to go beyond 'checking the boxes' and address the root cau
‘The companies who export must comply with the regulations of the importing country’
Sudhanshu Pandey, Joint Secretary, Department of Commerce, Ministry of Commerce & Industry, Government of India takes some tough questions from Viveka Roychowdhury on the sidelines of the recently hel
Pharma quality assurance in 21st century: Sharper focus needed on education, training and experience
Ajaz S Hussain, Founder CEO, Insight Advice & Solutions, and President, The National Institute for Pharmaceutical Technology & Education (NIPTE), US, opines that there is a need to develop curricula
Building quality excellence in pharma industry
With the pharma industry expanding scale and complexity, quality has emerged as a major focus area. Is quality merely a risk to be mitigated or does it represent an opportunity to create real value an
Pharma quality and compliance: Has the ‘elephant in the boardroom’ been recognised?
SM Mudda, Chairman, Regulatory Affairs Committee, IDMA, Mumbai examines where India’s pharma industry stands in terms of current expectations of the regulatory authorities and the state of GMP comp
Indian pharma: Bad at GMP compliance or victim of unwarranted regulatory expectations?
Viranchi Shah, Vice Chairman, Indian Drug Manufacturers’ Association (IDMA), opines that India's role in global healthcare cannot be decimated or questioned only due to recent concerns but cautions
Tackling GMP non-compliance: A top priority!
Suresh Pareek,Managing Director, Ideal Cures emphasises the importance of eliminating GMP non-compliance and points out that its responsibility lies with each employee in an organisation
Battling non-conformance to quality
Michael Payne, Principal Technical Consultant, Process Solutions, Merck elaborates on the need to evaluate the quality systems in pharma organisations and plug the gaps to reduce non-conformance and
Setting up greenfield projects: Doing it the right way!
Vilas Dholye, Independent Pharma Consultant outlines the measures that need to be implemented at the planning/ construction stage of a greenfield project to avoid issues of non-compliance to quality s
Information security of computerised systems for global compliance
Arjun Guha Thakurta, Director – Operations, Life Science Consulting (a Convalgroup Company), emphasises on deploying an effective computerised system to defend critical electronic data and comply wi
Transforming businesses from good to great!
Dr Shruti U Bhat, Director Strategic Innovations, Continuous improvement and Training; Shifting Paradigms BC Canada elaborates on how companies can stay healthy and grow despite rapid changes such as
Drug metabolism – Metabolite identification using advance LC-MS/MS system
Dr Vijayabhasker V, Principal Scientist, GVK Bio, Hyderabad, Dr Pratima Srivastava, Associate Director, Biology, GVK Bio, Hyderabad, Dr Anoop Kumar, Application Support Manager, Sciex India and Dr Man
Still leading the race?
Maharashtra, a traditional hub of the Indian pharma industry, could face an uphill task to retain its decades-old dominance in this sector By Sachin Jagdale
Maharashtra, the pharma capital
Suresh G Kare, Chairman, Indoco Remedies, elaborates why Maharashtra has been a preferred destination for the pharma sector
Pharma sector in Maharashtra till now and it will be…….
Shashank Sandu, Director, Sandu Pharmaceuticals, elaborates on how Maharashtra has become a favourite destination for pharma cos
A portal for progress?
It is only five months since India’s central drug authority launched its online licensing services portal, SUGAM. But the regulator needs to settle niggling doubts fast if it wants to catch the Digi
Role of social media in pharma industry
Dinesh Chindarkar, Co-Founder of MediaMedic Communications, elaborates on how pharma marketing is undergoing a paradigm shift with the advent of social media
A Mixed Bag of Reactions
Though the life sciences sector has stored some good points in Union Budget 2016, it has evoked a mixed response from industry experts
Waiting to IPO?
Will the bullish response to last year's IPOs in the pharma and healthcare sector spur more companies to test the market in 2016? Will these hopefuls succeed in timing their IPOs just right? Or is thi
In Need of Renewed Focus
Pharma MSMEs will miss the Make in India bus unless they upgrade to global norms. But industry stalwarts point out that the government needs to do more to help them move up to the next level. By Usha
Wish List for Budget 2016
Industry stakeholders share their wish list for the pharma industry from the forthcoming budget
Advertisement
Most Read
- RIL Q1 results HIGHLIGHTS: Reliance Retail net profit more than doubles on-yr; Jio net grows 45%
- Covid LIVE: India’s cumulative vaccination crosses 42.75-crore-mark; 17,518 new COVID-19 cases in Kerala; Mumbai reports 374 new cases
- How to get regular monthly returns with capital appreciation in the long term?
- Tokyo 2020 Olympics open sans customary razzle dazzle: Check out Opening Ceremony images
- Reliance Jio profits jumps 44.9% to Rs 3,651 cr with net addition of 14.3 million subscribers during Apr-June
- How will RBI's CBDC impact bank deposits, payments and private cryptocurrencies? 5 points
- Pegasus spyware: Telegram founder says he was aware of being a target since 2018
- INS Tabar reaches Moscow to take part in the Russian Navy Celebrations
- Zomato listing HIGHLIGHTS: Share price ends first day of trade at Rs 126; jumps 66% from IPO price
- Amazon Prime Day to enable small businesses bounce back and generate demand, said its MSME Director Pranav Bhasin
Advertisement
Top News
- RIL Q1 results HIGHLIGHTS: Reliance Retail net profit more than doubles on-yr; Jio net grows 45%
- Covid LIVE: India’s cumulative vaccination crosses 42.75-crore-mark; 17,518 new COVID-19 cases in Kerala; Mumbai reports 374 new cases
- How to get regular monthly returns with capital appreciation in the long term?
- Tokyo 2020 Olympics open sans customary razzle dazzle: Check out Opening Ceremony images
- Reliance Jio profits jumps 44.9% to Rs 3,651 cr with net addition of 14.3 million subscribers during Apr-June
- How will RBI's CBDC impact bank deposits, payments and private cryptocurrencies? 5 points
- Pegasus spyware: Telegram founder says he was aware of being a target since 2018
- INS Tabar reaches Moscow to take part in the Russian Navy Celebrations
- Zomato listing HIGHLIGHTS: Share price ends first day of trade at Rs 126; jumps 66% from IPO price
- Amazon Prime Day to enable small businesses bounce back and generate demand, said its MSME Director Pranav Bhasin
Advertisement
